Terms: = Germ cell tumor AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Clinical Outcome
4 results:
1. Musashi-1 Enhances Glioblastoma cell Migration and Cytoskeletal Dynamics through Translational Inhibition of Tensin3.
Chen HY; Lin LT; Wang ML; Laurent B; Hsu CH; Pan CM; Jiang WR; Chen PY; Ma HI; Chen YW; Huang PI; Chiou A; Chiou SH
Sci Rep; 2017 Aug; 7(1):8710. PubMed ID: 28821879
[TBL] [Abstract] [Full Text] [Related]
2. Glycerophosphodiesterase GDE2 Promotes Neuroblastoma Differentiation through Glypican Release and Is a Marker of clinical outcome.
Matas-Rico E; van Veen M; Leyton-Puig D; van den Berg J; Koster J; Kedziora KM; Molenaar B; Weerts MJ; de Rink I; Medema RH; Giepmans BN; Perrakis A; Jalink K; Versteeg R; Moolenaar WH
Cancer Cell; 2016 Oct; 30(4):548-562. PubMed ID: 27693046
[TBL] [Abstract] [Full Text] [Related]
3. HIF-1α genetic variants and protein expression confer the susceptibility and prognosis of gliomas.
Yi L; Hou X; Zhou J; Xu L; Ouyang Q; Liang H; Zheng Z; Chen H; Xu M
Neuromolecular Med; 2014 Sep; 16(3):578-86. PubMed ID: 24929654
[TBL] [Abstract] [Full Text] [Related]
4. Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival.
Ernst A; Hofmann S; Ahmadi R; Becker N; Korshunov A; Engel F; Hartmann C; Felsberg J; Sabel M; Peterziel H; Durchdewald M; Hess J; Barbus S; Campos B; Starzinski-Powitz A; Unterberg A; Reifenberger G; Lichter P; Herold-Mende C; Radlwimmer B
Clin Cancer Res; 2009 Nov; 15(21):6541-50. PubMed ID: 19861460
[TBL] [Abstract] [Full Text] [Related]
